Concord Biotech Limited IPO (Concord Biotech IPO) Detail

Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.

Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.

The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.

Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.

Concord Biotech IPO Details

Concord Biotech IPO is a Book Built Issue. The IPO total issue size is Rs 1,551.00 Cr. The Concord Biotech IPO price is ₹705 to ₹741 per share. The IPO will list on BSE, NSE.

IPO Date	Aug 4, 2023 to Aug 8, 2023
Listing Date	Aug 18, 2023
Face Value	₹1 per share
Price	₹705 to ₹741 per share
Lot Size	20 Shares
Total Issue Size	20,925,652 shares (aggregating up to ₹1,551.00 Cr)
Offer for Sale	20,925,652 shares of ₹1 (aggregating up to ₹1,551.00 Cr)
Employee Discount	Rs 70 per share
Issue Type	Book Built Issue IPO
Listing At	BSE, NSE
Share holding pre issue	104,616,204
Share holding post issue	104,616,204

Concord Biotech IPO Reservation

Concord Biotech IPO a total of 20,925,652 shares are offered. QIB: 4,183,130 (19.99%), RII: 7,320,479 (34.98%), NII: 3,137,348 (14.99%).

Anchor Investor Shares Offered	6,274,695 (29.99%)
QIB Shares Offered	4,183,130 (19.99%)
NII (HNI) Shares Offered	3,137,348 (14.99%)
Retail Shares Offered	7,320,479 (34.98%)
Employee Shares Offered	10,000 (0.05%)
Total Shares Offered	20,925,652 (100%)

Concord Biotech IPO Anchor Investors Details

Concord Biotech IPO raises Rs 464.95 crore from anchor investors. Concord Biotech IPO Anchor bid date is Aug 3, 2023.

Bid Date	Aug 3, 2023
Shares Offered	6,274,695
Anchor Portion Size (In Cr.)	464.95
Anchor lock-in period end date for 50% shares (30 Days)	Sep 26, 2023
Anchor lock-in period end date for remaining shares (90 Days)	Dec 26, 2023

Concord Biotech IPO Timetable (Tentative)

Concord Biotech IPO opens on Aug 4, 2023, and closes on Aug 8, 2023.

IPO Open Date	Friday, 4 August 2023
IPO Close Date	Tuesday, 8 August 2023
Basis of Allotment	Friday, 11 August 2023
Initiation of Refunds	Monday, 14 August 2023
Credit of Shares to Demat	Thursday, 17 August 2023
Listing Date	Friday, 18 August 2023
Cut-off time for UPI mandate confirmation	5 PM on Aug 8, 2023

Concord Biotech IPO Lot Size

The minimum lot size of this Concord Biotech IPO is 20 shares required is ₹14,820.

Application	Lots	Shares	Amount
Retail (Min)	1	20	₹14,820
Retail (Max)	13	260	₹192,660
S-HNI (Min)	14	280	₹207,480
S-HNI (Max)	67	1,340	₹992,940
B-HNI (Min)	68	1,360	₹1,007,760

Concord Biotech IPO Promoter Holding

Sudhir Vaid and Ankur Vaid are the Company Promoters.

Pre Issue Share Holding	44.08%
Post Issue Share Holding	44.08%

Company Financials

Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Key Performance Indicator

Concord Biotech IPO Market Cap is Rs 7752.06 Cr and P/E (x) is 32.29.

KPI	Values
P/E (x)	32.29
Market Cap (₹ Cr.)	7752.06
ROE	20.06%
ROCE	24.27%
EPS (Rs)	20.79
RoNW	20%